Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

WFNOS Magazine

The inaugural issue of the official publication of the World Federation of Neuro-Oncology Societies is ...

Read Full Story

Neuro-Oncology Review Course at SNO

November 16, 2016. Register in conjunction with the SNO Annual Meeting

Read Full Story

CNS Anticancer Drug Discovery and Development Conference

Register Now!

Read Full Story
View All News


EANO 2016

Read Full Story


18th Annual Brain Tumor Update and 7th Annual International Symposium on Long-Term Control of Metastases to the Brain and Spine

Read Full Story


2nd CNS Anticancer Drug Discovery/Development Conference

Read Full Story

2013 Neuro Tumor Club Dinner at AACR

Washington Plaza Hotel, 10 Thomas Circle, NW
Washington, DC 
Monday April 8, 2013, 6:30–10:00pm
No Charge to Attend - RSVP Required
Deadline to register your attendance Monday, April 1
6:30-7:00  Buffet Dinner Service
7:00-7:05  Welcome & Introduction: Co-Chairs John Park and Raymund Yong, National Institutes of Health
Session 1
Animal Models, Biomarkers and Stem Cells
7:05-7:10   Overview: Justin Lathia, Cleveland Clinic Foundation, Cleveland, OH
7:10-7:20   Genetic Mosaic Mouse Models for Brain Tumors: Basic Research and Pre-Clinical Applications
                  Hui Zong, University of Virginia, Charlottesville, VA
7:20-7:30   sncRNA Signature Found in Microvesicles of GBM Patient Serum Serves as a Diagnostic Marker      
                  Marta Alonso, University Hospital of Navarra, Spain
7:30-7:40   A Human Neural Stem Cell Model of MYC-Driven Medulloblastoma Reveals
                  Glutamine Metabolism as a Potential Therapeutic Target
                  Allison Hanaford, Johns Hopkins University School of Medicine, Baltimore, MD
7:40-7:50   A Proneural Signature Profile Predicts Response to Notch Inhibition in Glioma Tumor Initiating Cells
                  Norihiko Saito, UT M.D. Anderson Cancer Center, Houston, TX
Session 2
CNS Metastases
7:50-7:55   Overview: Yaacov Lawrence, Sheba Medical Center, Tel Hashomer, Israel
7:55-8;05   2B3-101, a Brain-Targeted Doxorubicin Formulation Shows Promising Preclinical and Early Clinical Results
                  Pieter Gailard, to-BBB technologies BV, Leiden, The Netherlands
8:05-8:15   The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis
                  Dario Marchetti, Baylor College of Medicine, Houston, TX

8:15-8:25   Microenvironment-induced Changes in miRNA Levels Promote Brain Metastasis      
                  James Driscoll, University of Cincinnati, Cincinnati, OH

Session 3
Geno/Phenotyping and Personalized/Combinatorial Therapy
8:25-8:30   Overview: Vivek Subbiah, UT M.D. Anderson Cancer Center, Houston, TX
8:30-8:40   Role Of Intratumoral Cell Heterogeneity on Therapeutic Efficacy in Glioblastoma
                  Debyani Chakravarty, Memorial Sloan-Kettering Cancer Center, New York, NY
8:40-8:50   Effective Targeting of the cMET Pathway in Sonic Hedgehog Medulloblastoma
                  Claudia Faria, The Hospital for Sick Children, Toronto, ON, Canada
8:50-9:00   Combination of SapC-DOPS with Rapamycin Induces Synergistic Interactions In Glioma
                  Jeffrey Wojton, Ohio State University, Columbus, OH
9:00-9:10  Genomic sequencing of Meningiomas Identified Oncogenic AKT1 and SMO Mutations
                   Priscilla Brastianos, Massachusetts General Hospital, Boston, MA 

Session 4
New Gene and Immunotherapy
9:10-9:15  Overview: Allen Waziri, University of Colorado, Aurora, CO
9:15-9:25   Increase in Tumor-associated Macrophages (TAMs) after Antiangiogenic Therapy
                  is Associated with Poor Survival in Recurrent Glioblastoma (GBM) Patients
                  Jennie Taylor, Massachusetts General Hospital, Boston, MA
9:25-9:35    T cell Receptor Sequencing for Immunological Correlates of Glioma Progression  
                   Jennifer Sims, Columbia University, New York, NY
9:35-9:45    Down-Regulation of Ferritin Heavy Chain as an Adjuvant Therapy in Human Glioma
                   Min Pang, Penn State Hershey College of Medicine, Hershey, PA
NOTE: Each talk is 5 minutes, followed by a 5 minute discussion